You have 9 free searches left this month | for more free features.

City

Baltimore (1)

Chicago (1)

Minneapolis (1)

Saint Paul (1)

Condition

Neuroendocrine Tumors (1)

Pancreatic Neuroendocrine Tumor (1)

Solid Tumor (1)

Uveal Melanoma (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Arkadiusz Z. Dudek, MD (1)

Vanquish Oncology, Inc. (1)

Collaborator

Genentech, Inc. (1)

HealthPartners Regions Cancer Care and Frauenshuh Cancer Care Centers (1)

Midwest Melanoma Partnership (1)

University of Illinois at Chicago (1)

Vanquish Oncology, Inc. (1)

Intervention

pac-1 (2)

entrectinib (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

pac-1

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Uveal Melanoma Trial in Minneapolis (PAC-1, Entrectinib)

Active, not recruiting

Uveal Melanoma

PAC-1
Entrectinib

Minneapolis, Minnesota

HealthPartners Institute Regions Cancer Care Center

Nov 15, 2022

Solid Tumor, Pancreatic Neuroendocrine Tumor, Neuroendocrine Tumors Trial in Chicago, Baltimore, Saint Paul (PAC-1)

Completed

Solid Tumor
+2 more

PAC-1

Chicago, Illinois
+2 more

Sep 22, 2020